Browsing by Author Syrrou, M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 46  next >
TitleAuthor(s)Issue date
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasmsHatzimichael, E.; Dasoula, A.; Benetatos, L.; Makis, A.; Stebbing, J.; Crook, T.; Syrrou, M.; Bourantas, K. L.24-Nov-2015
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasiaHatzimichael, E.; Benetatos, L.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Georgiou, I.; Syrrou, M.; Stebbing, J.; Coley, H. M.; Crook, T.; Bourantas, K. L.24-Nov-2015
Absence of mutations of the EPO-receptor gene in Greek patients with familial polycythemiaBourantas, L. K.; Chatzikyriakidou, A.; Dasoula, A.; Syrrou, M.; Bournatas, K. L.; Georgiou, I.24-Nov-2015
Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populationsWitsch-Baumgartner, M.; Schwentner, I.; Gruber, M.; Benlian, P.; Bertranpetit, J.; Bieth, E.; Chevy, F.; Clusellas, N.; Estivill, X.; Gasparini, G.; Giros, M.; Kelley, R. I.; Krajewska-Walasek, M.; Menzel, J.; Miettinen, T.; Ogorelkova, M.; Rossi, M.; Scala, I.; Schinzel, A.; Schmidt, K.; Schonitzer, D.; Seemanova, E.; Sperling, K.; Syrrou, M.; Talmud, P. J.; Wollnik, B.; Krawczak, M.; Labuda, D.; Utermann, G.24-Nov-2015
Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson diseaseVoutsinas, G. E.; Stavrou, E. F.; Karousos, G.; Dasoula, A.; Papachatzopoulou, A.; Syrrou, M.; Verkerk, A. J.; van der Spek, P.; Patrinos, G. P.; Stoger, R.; Athanassiadou, A.24-Nov-2015
Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpressionMalamou-Mitsi, V. D.; Syrrou, M.; Georgiou, I.; Pagoulatos, G.; Agnantis, N. J.24-Nov-2015
Angiotensin II type 2 receptor gene polymorphism in Caucasian children with a wide spectrum of congenital anomalies of the kidney and urinary tractSiomou, E.; Bouba, I.; Kollios, K. D.; Papadopoulou, F.; Syrrou, M.; Georgiou, I.; Siamopoulou, A.24-Nov-2015
Association of estrogen receptor gene polymorphisms with endometriosisGeorgiou, I.; Syrrou, M.; Bouba, I.; Dalkalitsis, N.; Paschopoulos, M.; Navrozoglou, I.; Lolis, D.24-Nov-2015
Autosomal folate sensitive fragile sites in normal and mentally retarded individuals in GreeceMavrou, A.; Syrrou, M.; Tsenghi, C.; Metaxotou, C.24-Nov-2015
A case of abetalipoproteinemia with a choreic-ataxic syndrome and none of the known mutationsKonitsiotis, S.; Mokou, C.; Kalantaridou, S.; Syrrou, M.; Kravariti, M.; Tsatoulis, A.24-Nov-2015
A case of fetal intestinal tract distensions: prenatal biochemical and ultrasound evaluationStefos, T.; Georgiou, I.; Syrrou, M.; Lollis, D.24-Nov-2015
Chromomycin A3-staining as an indicator of protamine deficiency and fertilizationLolis, D.; Georgiou, I.; Syrrou, M.; Zikopoulos, K.; Konstantelli, M.; Messinis, I.24-Nov-2015
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromesBenetatos, L.; Hatzimichael, E.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Syrrou, M.; Georgiou, I.; Bourantas, K. L.24-Nov-2015
Dysmorphology and mental retardation: molecular cytogenetic studies in dysmorphic mentally retarded patientsVan Buggenhout, G. J.; van Ravenswaaij-Arts, C.; Mieloo, H.; Syrrou, M.; Hamel, B.; Brunner, H.; Fryns, J. P.24-Nov-2015
Effect of Percoll gradient and swim-up preparation on the chromomycin A3 staining of normal and abnormal semen samplesGeorgiou, I.; Syrrou, M.; Stefanidis, K.; Konstantelli, M.; Lolis, D.24-Nov-2015
Evidence for high-risk haplotypes and (CGG)n expansion in fragile X syndrome in the Hellenic population of Greece and CyprusSyrrou, M.; Patsalis, P. C.; Georgiou, I.; Hadjimarcou, M. I.; Constantinou-Deltas, C. D.; Pagoulatos, G.24-Nov-2015
Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunctionSyrrou, M.; Georgiou, I.; Patsalis, P. C.; Bouba, I.; Adonakis, G.; Pagoulatos, G. N.24-Nov-2015
FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic populationSyrrou, M.; Georgiou, I.; Grigoriadou, M.; Petersen, M. B.; Kitsiou, S.; Pagoulatos, G.; Patsalis, P. C.24-Nov-2015
A gene for nonsyndromic X-linked mental retardation (MRX77) maps to Xq12-Xq21.33Sismani, C.; Syrrou, M.; Christodoulou, K.; Hamel, B.; Chelly, J.; Yntema, H. G.; van Bokhoven, H.; Tzoufi, M.; Georgiou, I.; Patsalis, P. C.24-Nov-2015
Genetic and epigenetic risks of intracytoplasmic sperm injection methodGeorgiou, I.; Syrrou, M.; Pardalidis, N.; Karakitsios, K.; Mantzavinos, T.; Giotitsas, N.; Loutradis, D.; Dimitriadis, F.; Saito, M.; Miyagawa, I.; Tzoumis, P.; Sylakos, A.; Kanakas, N.; Moustakareas, T.; Baltogiannis, D.; Touloupides, S.; Giannakis, D.; Fatouros, M.; Sofikitis, N.24-Nov-2015